PED3006 : Carcinogenesis and Anticancer Drugs
- Offered for Year: 2017/18
- Module Leader(s): Professor John Lunec
- Demonstrator: Dr Yvette Drew
- Lecturer: Professor Julie Irving, Dr Nicola Cresti, Dr Elaine Willmore, Dr Sally Hall, Dr Jennifer Bonner, Dr David Jamieson, Professor Nicola Curtin, Dr Gareth Veal, Professor Steve Wedge
- Owning School: Biomedical Sciences
- Teaching Location: Newcastle City Campus
|Semester 1 Credit Value:||10|
To provide information and develop the students understanding of the process of carcinogenesis, on the biology of cancer cells, on oncogenes and tumour suppressor genes and on the pharmacology of the main anticancer drugs and explore new pharmacological strategies in the treatment of cancer.
Outline Of Syllabus
|Scheduled Learning And Teaching Activities||Lecture||16||1:00||16:00||N/A|
|Scheduled Learning And Teaching Activities||Small group teaching||1||2:00||2:00||Seminars|
|Guided Independent Study||Independent study||1||82:00||82:00||Private study|
Teaching Rationale And Relationship
The lectures provide the majority of the knowledge, together with information on novel approaches to cancer treatment. The seminar session consists of the presentation of a research paper by each student, giving them the opportunity to investigate an aspect of the course material in more detail
The format of resits will be determined by the Board of Examiners
|Written Examination||90||2||A||80||One question from a choice of two and two shorter questions from a choice of 3|
|Prof skill assessmnt||1||M||20||Oral presentation 5 mins/student plus Q&A time|
Assessment Rationale And Relationship
FMS Schools offering Semester One modules available as ‘Study Abroad’ will, where required, provide an alternative assessment time for examinations that take place after the Christmas vacation. Coursework with submissions dates after the Christmas vacation will either be submitted at an earlier date or at the same time remotely.
The form of assessment will not vary from the original.